A Trial Comparing the Safety and Efficacy of Semaglutide Once Weekly Versus Sitagliptin Once Daily in Japanese Subjects With Type 2 Diabetes
Clinical trial NCT02254291 · COMPLETED
Trial details
- NCT number
- NCT02254291
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-10-02
- Primary completion
- 2015-11-11
- Enrollment
- 308
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.